Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

20.99 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,785
Open 20.99
Bid (Size) 21.30 (1)
Ask (Size) 21.37 (6)
Prev. Close 20.99
Today's Range 20.99 - 20.99
52wk Range 7.500 - 30.44
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Price Over Earnings Overview: Hims & Hers Health
Via Benzinga

Performance

YTD
+117.74%
+117.74%
1 Month
-8.94%
-8.94%
3 Month
+26.75%
+26.75%
6 Month
+12.85%
+12.85%
1 Year
+171.19%
+171.19%

More News

Read More
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
Via Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Via The Motley Fool
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Peering Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
From Volatility To Opportunity: Key Stocks Poised To Shine Today
Via Talk Markets
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Via Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
From Hims & Hers
Via Business Wire
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
Via Chartmill
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
Via The Motley Fool
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
Via MarketBeat
Tesla, Trump Trades, And Tech: Top Stocks To Watch Today
Via Talk Markets
Topics Government
Exposures Political
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Via Benzinga
We Tested Top Stocks; Here’s What’s Best For Your Money
Via Talk Markets
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Via The Motley Fool
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
Via The Motley Fool
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.